NCT03420833

Metabolic Mapping and Cardiac Resynchronization

Metabolic Mapping and Cardiac Resynchronization (Aim 1)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: Yong-Mei Cha · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to gather information on the safety and effectiveness of cardiac resynchronization therapy (CRT) in patients who have mild heart failure (HF) and left bundle branch block (LBBB).

Conditions

• Heart Failure

Interventions

Type	Name	Description
DEVICE	Cardiac resynchronization therapy pacemaker (CRT-P)	A pacemaker is an implantable, battery-powered minicomputer that sends electrical pulses to the heart whenever it detects a slow heartbeat or no heartbeat at all. When it senses a slow heartbeat or lack of heartbeat, it sends electrical impulses to restore a normal rhythm. Cardiac resynchronization therapy pacemakers, or CRT-Ps, treat heart failure by resynchronizing electrical impulses in the heart's four chambers, improving the heart's ability to pump blood to the body effectively and efficiently.

Timeline

• Start date: 2018-08-20
• Primary completion: 2023-12-19
• Completion: 2023-12-19
• First posted: 2018-02-05
• Last updated: 2025-01-23
• Results posted: 2025-01-23

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study